Hyster-Yale, Inc. (HY)

From the record

Hyster-Yale, Inc.'s filings since 2017 show no warning events in the scan: no bankruptcy or receivership notice, no debt default notice, no exchange listing notice, no restatement warning, no auditor change, no material cyber incident and no late-report notice (its current reports).

From the record

Hyster-Yale, Inc.'s 10 filed years say what it did: revenue went from $2.6 billion in fiscal 2016 to $3.8 billion in fiscal 2025, up 4.3% a year; it rose in 7 of 9 years; the deepest fall was 15% from fiscal 2019 to fiscal 2020; net income was positive in 7 of 10 of those years (its annual reports).

From the record

Over the 3 fiscal years to 2025-12-31, Hyster-Yale, Inc.'s diluted share count grew about 1.5% a year, and dividends and buybacks returned about 22% of its operating cash flow over 3 years (its filed statements). Its officers and directors filed 0 sales and 0 purchases of their own stock on the open market in the year to 2026-11-03 (their Form 4 filings).

From the record

Return on equity: in the fiscal year ended 2025-12-31, Hyster-Yale, Inc. lost about 13 cents for every dollar of shareholders' money, and gross profitability: its products earned about 31 cents per dollar of everything the company owns. Leverage: it owed about 76 cents per dollar of assets, and net share issuance: its share count shrank 0.2% over the year (the filed statements).

From the record

Hyster-Yale, Inc.'s standing among 63 graded names in its industry family: revenue of $3.8 billion in fiscal 2025 ranks in the top 44% by size; a net margin of -1.6% ranks in the bottom 21%; revenue growth of 2% a year over the last 3 filed years ranks in the bottom 42% (its annual reports).

From the record

Hyster-Yale, Inc.'s leadership, from its insiders' filings and its current reports: no one files under a chief executive's title, so that part is not read; the 22 officers and directors filing in the last fifteen months have been on the record a median of 12.1 years (top 3%); 8 officer or director changes were reported on Form 8-K since 2023-11-13, against the 22 people in charge now (top 41%; fewer changes for each person reads higher) (the Form 4 record, its Form 8-K reports). Years count from a person's first filing in the SEC's data sets, which begin in 2006, so each is a floor.

From the record

Hyster-Yale, Inc.'s room to grow, from the newest filed statements (fiscal 2025): cash of $123 million against debt of $473 million leaves -17.3% of its assets as net cash, bottom 41% of its family; cash from operations less capital spending is 0.6% of revenue (bottom 25%); a gross margin of 16.8% (bottom 6%); research spending of 3.6% of revenue (top 37%) (its annual report).

From the record

Hyster-Yale, Inc.'s growth drivers, from the filed years to fiscal 2025: revenue grew 2% a year over the last three filed years against 4.3% over all 10, slowing (bottom 37% of its family); the newest year grew -12.5% (bottom 4%); research spending grew 10.9% a year (top 23%); capital spending grew 29.5% a year (top 10%) (its annual reports). Hyster-Yale, Inc. reported 3 lines of business in fiscal 2025: Americas HY at $2.8 billion (76%), EMEAHY at $570 million (15%), Bolzoni at $333 million (9%); 0 of 3 grew against the year before (its annual report).

From the record

Hyster-Yale, Inc.'s newest year against its own record: revenue of $3.8 billion in fiscal 2025 came in 20.6% below the $4.7 billion its prior three years' pace pointed to (bottom 1% of its family); net income of $60 million against a prior three-year average of $65 million (bottom 6%); a net margin of -1.6% against 1.4% before (bottom 30%) (its annual reports).